Revises full year 2025 Net Sales, Adjusted EBITDA, and Adjusted Free Cash Flow guidanceReaffirms cost synergy capture targets of $200 million in 2025; $300...
Second Quarter 2025 Renewables SBU Adjusted EBITDA Grew 56% Versus Second Quarter 2024
Strategic Accomplishments
On track to add 3.2 GW of new projects in operation in...
ROCKVILLE, Md. and SUZHOU, China, July 07, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced the appointments of Veet Misra, Ph.D., as the Company’s Chief Financial Officer, and Mr. Eric Huang, as Senior Vice President of Global Corporate Development and Finance. Both Dr. Misra and Mr. Huang will report directly to Dajun Yang, M.D., Ph.D., the Company’s Chairman & Chief Executive Officer.
Iceland Seafood International hf. (“ISI hf.”) announces the successful conclusion of its refinancing, significantly strengthening the company’s financial position through debt restructuring, interest rate reduction, and enhanced liquidity.